Screener
Acadia Pharmaceuticals ACAD Gross margin
Gross margin at other companies
Other financials
Where this comes from
Calculated from Acadia Pharmaceuticals’s reported figures.
Based on trailing twelve months.
The source filing: Acadia Pharmaceuticals’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 4, 2026, 8:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-333243
FAQ
- What is Acadia Pharmaceuticals's gross margin?
- Acadia Pharmaceuticals (ACAD) reported gross margin of 91.1% in Q2 2026.
- How has Acadia Pharmaceuticals's gross margin changed year-over-year?
- Acadia Pharmaceuticals's gross margin decreased by 0.9% year-over-year, from 92% to 91.1%.
- What is the long-term trend for Acadia Pharmaceuticals's gross margin?
- Over 5 years (2020 to 2025), Acadia Pharmaceuticals's gross margin has grown at a -1.3% compound annual growth rate (CAGR), from 97.7% to 91.7%.
- What does gross margin mean?
- Gross profit (revenue minus cost of revenue) as a percentage of revenue, on a trailing-twelve-month basis. Measures how much of each sales dollar survives the direct cost of producing the goods or services sold.
Ask your AI about Acadia Pharmaceuticals's gross margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude